Myelo Therapeutics GmbH
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Subsidiary
- Established
- 2013-01-01
- Employees
- 1
- Market Cap
- -
Efficacy and Safety Phase IIa Study of Myelo001 in Chemotherapy-Induced Neutropenia
Phase 2
Completed
- Conditions
- Chemotherapy-Induced NeutropeniaMyelosuppressionBreast Cancer
- Interventions
- Drug: Placebo
- First Posted Date
- 2016-02-26
- Last Posted Date
- 2017-11-24
- Lead Sponsor
- Myelo Therapeutics GmbH
- Target Recruit Count
- 137
- Registration Number
- NCT02692742
- Locations
- 🇩🇪
Site 10, Hannover, Germany
🇩🇪Site 20, Aachen, Germany
🇩🇪Site 21, Dresden, Germany
© Copyright 2025. All Rights Reserved by MedPath